PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fortitech, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Fortitech South America Focuses on Functional Confections at FISA - At Food Ingredients South America (FISA), Fortitech South America focused on improving and maintaining the wellness of its aging population within that region – but in a non-traditional manner
Fortitech South America Focuses on Functional Confections at FISA

 

NewswireToday - /newswire/ - Schenectady, NY, United States, 2006/09/20 - At Food Ingredients South America (FISA), Fortitech South America focused on improving and maintaining the wellness of its aging population within that region – but in a non-traditional manner.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Not showing interest in taking mega-doses of nutrients or supplements, current trends suggest older adults are actively looking to find exciting and more pleasurable ways of receiving their nutrition – without sacrificing good taste or texture.

Fortitech South America offered several new fortified applications that meet this demand. To get a solid nutrient boost, attendees dipped fresh fruit in fortified melted chocolate. This fortified confection is a delicious, smooth and well-rounded treat, blended with more than 15 essential vitamins and minerals. The functional profile of this chocolate includes the B vitamins, antioxidants, calcium, folic acid, magnesium, zinc and iron, to name a few.

Fortitech South America also had two different fortified lollipops containing several healthy ingredients to give a nutritious boost. Our premix for the passion fruit flavored lollipops includes immunity-enhancing vitamins and minerals including vitamins A, C, iron and zinc. The premix for the apple flavored lollipops includes an excellent blend of overall nutrition targeting immunity, enhanced metabolism and increased energy. Nutrients in this application include vitamins A, C, B1, B2, B6, B12, folic acid and pantothenic acid.

Held in São Paulo, Brazil, FISA is one of the leading trade shows for new trends, solutions and technology for the food industry. The event is the world’s fourth largest food ingredients show and last year, more than 250 companies from 30 countries participated. The show also attracted more than 17,000 visitors in 2005.

About Fortitech South America
Fortitech South America (fortitech.com) is part of the global network of manufacturing and distribution companies of Fortitech, Inc., the world leader in the development of custom nutrient premixes for the food, beverage and pharmaceutical industries. Located in Campinas, Brazil, the company is exclusively dedicated to the manufacture of nutrient premixes. Fortitech South America is ISO 9001:2000 certified. The company also meets HACCP requirements and allergen monitoring program standards. FortiSource® - the ultimate fortification destination.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fortitech, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Fortitech South America Focuses on Functional Confections at FISA

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mark Fanion 
518-372-5155 info[.]fortitech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fortitech, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fortitech, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)